[ad_1]
According to a Reuters report, a Hungarian company in Syria has made significant progress to help produce coronavirus vaccines globally. Dr. Noémi Lukács founded a scientific consulting company called SciCons in his hometown, which aims to produce a sensitive genetic sensor that can supply a few grams to the entire world for years.
The “white powder” produced at the plant that operates in a small Hungarian town reaches the world in micrograms.
Emeritus Professor Noémi Lukács, former head of the Department of Plant Physiology and Biochemistry at the Faculty of Horticulture, SZIE, is receiving international attention. The Reuters news agency reported that Luke’s monoclinic antibodies, a unique substance in the world, recognize double-stranded RNA molecules (in other words, dsRNA). DsRNA is a by-product of viral replication and therefore can signal the presence of live viruses, including coronavirus.
DsRNA is also a by-product of the COVID-19 vaccine production process of the US pharmaceutical companies Pfizer and the German pharmaceutical companies BioNTech. This vaccine was more than 90 percent effective, based on last week’s test results.
DsRNA can be harmful to cells found in humans, so it must be removed from all vaccines, Mandiner advises. The most effective method of quality control is to expose the vaccine to Luke’s antibodies. The antibodies not only show if there are dsRNAs in the vaccine, they also “communicate” an exact number of how many of them.
The company is growing very fast, last year its sales revenue was 124 million HUF, with a profit of 52 million HUF. The company spends this amount on its employees’ salaries and on various local charitable projects.
[ad_2]
